Joe Pillman is the partner-in-charge of the firm's London-Alder Castle office and a member of the firm's Executive Committee. He joined the firm in 2000. He concentrates his practice on corporate finance, mergers and acquisitions and international law.
Practice
Mr. Pillman focuses on securities law, including public and private securities offerings, mergers and acquisitions, as well as a range of international matters, including public and private placements for overseas issuers, and inward and outward bound acquisition transactions. He also has extensive experience with management and leveraged buy-outs, venture capital transactions and other private fund raising issues.
Mr. Pillman's clients include companies engaged in a wide range of technology sectors such as life sciences, telecommunications equipment, networking systems, Internet infrastructure, semiconductor design and manufacture, and advanced software systems and applications products.
Recent Highlights
- MBO of PowderMed from Chiron
- Sale of Domantis to GSK
- Sale of Avidex to MediGene
Honors and Awards
Mr. Pillman has regularly been named as a leading corporate practitioner in Chambers Guide to the Legal Profession. He was also recommended in the 2008, 2009, 2010 and 2011 editions of Legal 500 UK for venture capital and mergers and acquisitions: lower mid market.